SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-09-024809
Filing Date
2009-05-08
Accepted
2009-05-07 20:11:56
Documents
6
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 v148203_10q.htm 10-Q 827045
2 GRAPHIC logo.jpg GRAPHIC 10929
3 v148203_ex31-1.htm EX-31.1 16326
4 v148203_ex31-2.htm EX-31.2 15814
5 v148203_ex32-1.htm EX-32.1 5801
6 v148203_ex32-2.htm EX-32.2 6158
  Complete submission text file 0001144204-09-024809.txt   887904
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 09807373
SIC: 2834 Pharmaceutical Preparations